{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:05:21Z","timestamp":1762866321186},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T00:00:00Z","timestamp":1512172800000},"content-version":"vor","delay-in-days":1462,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International Supplements"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/kisup.2013.94","type":"journal-article","created":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T18:39:57Z","timestamp":1385577597000},"page":"451-456","source":"Crossref","is-referenced-by-count":14,"title":["A Japanese approach for CKD-MBD"],"prefix":"10.1016","volume":"3","author":[{"given":"Keitaro","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/kisup.2013.94_bb0010","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Kidney Disease: Improving Global Outcome (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcome (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2013.94_bb0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2013.94_bb0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2013.94_bb0025","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca \u00d7 PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2013.94_bb0030","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","article-title":"Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes","volume":"15","author":"Stevens","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2013.94_bb0035","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2013.94_bb0040","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Pattern Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2013.94_bb0045","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","article-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study","volume":"16","author":"Slinin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2013.94_bb0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.ajkd.2005.04.006","article-title":"Mild hyperphosphatemia and mortality in hemodialysis patients","volume":"46","author":"Rodriguez-Benot","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2013.94_bb0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","article-title":"The Kidney Disease Outcomes Quality Initiative (K\/DOQI) Guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients","volume":"46","author":"Noordzij","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2013.94_bb0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2013.94_bb0065","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2013.94_bb0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2004.05.038","article-title":"Clinical significance of the K\/DOQI bone guidelines in Japan","volume":"44","author":"Yokoyama","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2013.94_bb0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","article-title":"Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients","volume":"12","author":"Guideline working group, Japanese Society for Dialysis Therapy","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"Supple 113","key":"10.1038\/kisup.2013.94_bb0080","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int"},{"issue":"4 Suppl 3","key":"10.1038\/kisup.2013.94_bb0085","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney F","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2013.94_bb0090","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","article-title":"Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients","volume":"12","author":"Guideline Working Group, Japanese Society for Dialysis Therapy","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1038\/kisup.2013.94_bb0095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ki.2008.175","article-title":"The calcium\u2013phosphorus in guidelines for CKD-MBD","volume":"74","author":"Yokoyama","year":"2008","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1038\/kisup.2013.94_bb0100","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1111\/j.1744-9987.2008.00631.x","article-title":"Impact of cinacalcet hydrochloride on the achievement of the Japanese Society of Dialysis Therapy (JSDT) guideline targets: a post-hoc analysis of the KRN 1493 study","volume":"12","author":"Komaba","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1038\/kisup.2013.94_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder","volume":"17","author":"Fukagawa","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1038\/kisup.2013.94_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1744-9987.2007.00540.x","article-title":"Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan","volume":"12","author":"Nakai","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1038\/kisup.2013.94_bb0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","article-title":"Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients","volume":"17","author":"Taniguchi","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1038\/kisup.2013.94_bb0120","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1681\/ASN.V1051090","article-title":"Effect of histamine H2-receptor antagonist on the phosphorus-binding abilities of calcium carbonate and calcium lactate in hemodialysis patients","volume":"10","author":"Takahashi","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2013.94_bb0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfm534","article-title":"Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients","volume":"23","author":"Fukagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2013.94_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5414\/CN107285","article-title":"Cinacalcet for hemodialyzed patients with or without a high PTH level to control serum calcium and phosphorus: ECO (Evaluation of Cinacalcet HCl Outcome) study","volume":"78","author":"Yokoyama","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1038\/kisup.2013.94_bb0135","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","article-title":"Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200\u2009mg once daily","volume":"44","author":"Harris","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2013.94_bb0140","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"5 Suppl 5","key":"10.1038\/kisup.2013.94_bb0145","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1053\/ajkd.2001.28113","article-title":"Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects","volume":"38","author":"Llach","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2013.94_bb0150","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/kisup.2013.94_bb0155","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","article-title":"Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study","volume":"26","author":"Naves-D\u00edaz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2013.94_bb0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000327654","article-title":"Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D","volume":"33","author":"Fukagawa","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1038\/kisup.2013.94_bb0165","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1038\/kisup.2013.94_bb0170","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1744-9987.2009.00772.x","article-title":"Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?","volume":"13","author":"Kakuta","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1038\/kisup.2013.94_bb0175","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2013.94_bb0180","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2215\/CJN.13081211","article-title":"Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study","volume":"7","author":"Fukagawa","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Kidney International Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2157171615311886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2157171615311886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T12:54:38Z","timestamp":1626872078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2157171615311886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2157171615311886"],"URL":"https:\/\/doi.org\/10.1038\/kisup.2013.94","relation":{},"ISSN":["2157-1716"],"issn-type":[{"value":"2157-1716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}